Slide 1
... • Cannabis use is harmful and should be prohibited • Evidence refracted through these views: • Supporters of status quo focused only on harm to users • Reformers focused only on harms from criminal law ...
... • Cannabis use is harmful and should be prohibited • Evidence refracted through these views: • Supporters of status quo focused only on harm to users • Reformers focused only on harms from criminal law ...
Viktor`s Notes * Attention Deficit Hyperactivity Disorder
... Inattention: at least 6 of 9 symptoms must have persisted for at least 6 months to degree that is maladaptive and inconsistent with patient's developmental level: 1) often does not give close attention to details or makes careless mistakes in schoolwork, work, or other activities. 2) often has diffi ...
... Inattention: at least 6 of 9 symptoms must have persisted for at least 6 months to degree that is maladaptive and inconsistent with patient's developmental level: 1) often does not give close attention to details or makes careless mistakes in schoolwork, work, or other activities. 2) often has diffi ...
DEPRESSION
... Partial Responders • Time to Next Episode: * 3 times longer to next episode remitters vs. partial responders • Quality of life (espec. Social Functioning) ...
... Partial Responders • Time to Next Episode: * 3 times longer to next episode remitters vs. partial responders • Quality of life (espec. Social Functioning) ...
recent advances in animal models of drug addiction
... indicative of an individual continuing substance use despite significant substance related problems, this term has become the accepted diagnostic term for compulsive use of a psychoactive substance. When defined as described, it is analogous to the term addiction. However, this term should not be co ...
... indicative of an individual continuing substance use despite significant substance related problems, this term has become the accepted diagnostic term for compulsive use of a psychoactive substance. When defined as described, it is analogous to the term addiction. However, this term should not be co ...
Joydip Das, Department of Pharmacological and Pharmaceutical
... as, doses of 1332 mg/day (666 mg in the morning, 333 mg at mid-day, and 333 mg in the evening) were administered for patients having body weight less or equal to 60 kg, and doses of 1998 mg/day (666 mg, 3 times daily) were administered for patients having body weight more than 60 kg. Efficacy in pro ...
... as, doses of 1332 mg/day (666 mg in the morning, 333 mg at mid-day, and 333 mg in the evening) were administered for patients having body weight less or equal to 60 kg, and doses of 1998 mg/day (666 mg, 3 times daily) were administered for patients having body weight more than 60 kg. Efficacy in pro ...
SYLLABUS FOR M.PHARM. IN PHARMACEUTICAL CHEMISTRY
... 1. Physicochemical properties in relation to drug action; metabolic transformation of drugs and its role in development of new drug molecules; Metabolic antagonism. 2. Stereochemical aspects of drug receptor interactions and mechanism of drug interaction. Isosterism and bioisosterism as guides to st ...
... 1. Physicochemical properties in relation to drug action; metabolic transformation of drugs and its role in development of new drug molecules; Metabolic antagonism. 2. Stereochemical aspects of drug receptor interactions and mechanism of drug interaction. Isosterism and bioisosterism as guides to st ...
Ecstasy and Club Drugs
... The Ecstasy high can last from 6 to 24 hours, with the average “trip” lasting only about 3-4 hours. Users of Ecstasy report that it causes mood changed and loosens their inhibitions; they become more outgoing, empathetic and affectionate. For this reason, Ecstasy has been called the “hug drug.” It a ...
... The Ecstasy high can last from 6 to 24 hours, with the average “trip” lasting only about 3-4 hours. Users of Ecstasy report that it causes mood changed and loosens their inhibitions; they become more outgoing, empathetic and affectionate. For this reason, Ecstasy has been called the “hug drug.” It a ...
2007 Guidelines for the Management of Arterial Hypertension
... Antihypertensive treatment is beneficial in hypertensive patients as well as in subjects with BP in the high normal range. So, BP goal should be <130/80 ...
... Antihypertensive treatment is beneficial in hypertensive patients as well as in subjects with BP in the high normal range. So, BP goal should be <130/80 ...
Document
... A. Minor alcohol withdrawal: It is characterized by mild autonomic hyperactivity. The specific withdrawal symptoms are usually the same from one episode to another in an individual. B. Alcoholic hallucinosis: They are usually visual but may be tactile or auditory. They occur in 10-25% of hospitalize ...
... A. Minor alcohol withdrawal: It is characterized by mild autonomic hyperactivity. The specific withdrawal symptoms are usually the same from one episode to another in an individual. B. Alcoholic hallucinosis: They are usually visual but may be tactile or auditory. They occur in 10-25% of hospitalize ...
NALTREXONE the facts about for Treatment of Opioid Addiction
... drug. Use is compulsive and continues even though the drug causes harm. Tolerance and dependence are common side effects of prescribed opioid medication that can be managed under a doctor’s care. Tolerance and dependence also are side effects from misuse of opioids. Addiction is not likely to develo ...
... drug. Use is compulsive and continues even though the drug causes harm. Tolerance and dependence are common side effects of prescribed opioid medication that can be managed under a doctor’s care. Tolerance and dependence also are side effects from misuse of opioids. Addiction is not likely to develo ...
Drugs with narrow therapeutic index as indicators in the risk
... range 15-98). 292 (35%) patients used at least one NTI-drug, while 535 (65%) did not use NTI-drugs (Table 1). A total of 217 patients (74% of the NTIusers) had one NTI-drug, whereas 69 (24%) used two and 6 (2%) used three NTI-drugs. More NTIusers than non-NTI-users had at least one DRP, 235 of the 2 ...
... range 15-98). 292 (35%) patients used at least one NTI-drug, while 535 (65%) did not use NTI-drugs (Table 1). A total of 217 patients (74% of the NTIusers) had one NTI-drug, whereas 69 (24%) used two and 6 (2%) used three NTI-drugs. More NTIusers than non-NTI-users had at least one DRP, 235 of the 2 ...
Frequently Asked Questions
... 11. I cannot find certain drugs listed on the PDL or RDL. What does this mean? New drug entities, including new generics and new drug product dosage forms of existing drug entities, are typically non-preferred initially and are not added to the PDL until after being reviewed by the P&T Committee for ...
... 11. I cannot find certain drugs listed on the PDL or RDL. What does this mean? New drug entities, including new generics and new drug product dosage forms of existing drug entities, are typically non-preferred initially and are not added to the PDL until after being reviewed by the P&T Committee for ...
One Step Multi-Drug Screen Test Card with Integrated E
... A drug-positive urine specimen will not generate a colored line in the specific test line region of the strip because of drug competition, while a drug-negative urine specimen will generate a line in the test line region because of the absence of drug competition. To serve as a procedural control, a ...
... A drug-positive urine specimen will not generate a colored line in the specific test line region of the strip because of drug competition, while a drug-negative urine specimen will generate a line in the test line region because of the absence of drug competition. To serve as a procedural control, a ...
MemberHealth - SilverScript
... ingredient by the FDA, they are not required to have the same “inactive” ingredients such as fillers and dyes. As always, talk with your doctor about any concerns you may have, and any opportunities to switch from a brand name drug to a generic. And remember that an up-to date list of all your pres ...
... ingredient by the FDA, they are not required to have the same “inactive” ingredients such as fillers and dyes. As always, talk with your doctor about any concerns you may have, and any opportunities to switch from a brand name drug to a generic. And remember that an up-to date list of all your pres ...
(1) Manipulate the barrier
... • TDD can closely duplicate continuous IV fusion. Hence it is helpful in delivering drugs that undergo significant first pass metabolism and/or have narrow therapeutic index ...
... • TDD can closely duplicate continuous IV fusion. Hence it is helpful in delivering drugs that undergo significant first pass metabolism and/or have narrow therapeutic index ...
Cardiovascular Drug Agents
... problems of congestive heart failure (CHF). In patients with congestive heart failure occurs when the ejection fraction compared with the total amount of blood in the ventricle is decreased. ...
... problems of congestive heart failure (CHF). In patients with congestive heart failure occurs when the ejection fraction compared with the total amount of blood in the ventricle is decreased. ...
VIEW PDF - Glaucoma Today
... In essence, the development of a drug delivery system involves two products, the active drug and the delivery system. If the system itself provides therapy (eg, a corrective contact lens that releases the drug), then it may be considered a combination product. The US FDA’s regulations for combinatio ...
... In essence, the development of a drug delivery system involves two products, the active drug and the delivery system. If the system itself provides therapy (eg, a corrective contact lens that releases the drug), then it may be considered a combination product. The US FDA’s regulations for combinatio ...
Medication-Assisted Treatment for Opiate Use Disorders
... Prior to joining Magellan, Dr. Henschen was Chief Medical Officer of Charter Behavioral Health Systems, LLC. He was previously in private practice for psychiatry and psychoanalysis in Greensboro, North Carolina for 15 years. Dr. Henschen is a graduate of Davidson College. He received the M.D. degree ...
... Prior to joining Magellan, Dr. Henschen was Chief Medical Officer of Charter Behavioral Health Systems, LLC. He was previously in private practice for psychiatry and psychoanalysis in Greensboro, North Carolina for 15 years. Dr. Henschen is a graduate of Davidson College. He received the M.D. degree ...
seminar on self emulsifying drug delivery system
... the excipient, which affects not only formulation performance, as well as visual appearance of formulation. Incompatibilities between the formulation and the gelatin capsules shell can lead to brittleness or deformation, delayed disintegration, or incomplete release of drug. For thermodynamic st ...
... the excipient, which affects not only formulation performance, as well as visual appearance of formulation. Incompatibilities between the formulation and the gelatin capsules shell can lead to brittleness or deformation, delayed disintegration, or incomplete release of drug. For thermodynamic st ...
FOM 2313 PHARMACOLOGY AND THERAPEUTICS
... 5. Impart teaching to the patient/family based on accurate assessment of their learning needs. 6. Utilize the rational drug use process to evaluate the need for and the effectiveness of the drug/s given to the patients. 7. Relate legal and ethical issues to the administration of drugs. 8. Incorporat ...
... 5. Impart teaching to the patient/family based on accurate assessment of their learning needs. 6. Utilize the rational drug use process to evaluate the need for and the effectiveness of the drug/s given to the patients. 7. Relate legal and ethical issues to the administration of drugs. 8. Incorporat ...
The Ups and Downs of Cognitive Enhancers
... functioning of a routine caffeine user. In fact, they almost certainly do. For example, the amount of sleep that one gets can very easily affect cognitive functioning, and while caffeine can offset the effects of a lack of sleep in the short-term, over a longer period of time these effects may begin ...
... functioning of a routine caffeine user. In fact, they almost certainly do. For example, the amount of sleep that one gets can very easily affect cognitive functioning, and while caffeine can offset the effects of a lack of sleep in the short-term, over a longer period of time these effects may begin ...
patient checklist - Community Pharmacy | Home
... 6) Are there any drug interactions of clinical significance? 7) Advise on safe storage of “take home” doses Section B: For patients who are new to Opioid Replacement Therapy (methadone/ Suboxone ® etc), returning after a break in treatment or new to pharmacy 1) Is starting dose appropriate? 2) Does ...
... 6) Are there any drug interactions of clinical significance? 7) Advise on safe storage of “take home” doses Section B: For patients who are new to Opioid Replacement Therapy (methadone/ Suboxone ® etc), returning after a break in treatment or new to pharmacy 1) Is starting dose appropriate? 2) Does ...
Polysubstance dependence
A person with polysubstance dependence is psychologically addicted to being in an intoxicated state without a preference for one particular substance. Although any combination of three drugs can be used, studies have shown that alcohol is commonly used with another substance. This is supported by one study on polysubstance use that separated participants who used multiple substances into groups based on their preferred drug. The three substances were cocaine, alcohol, and heroin, which implies that those three are very popular. Other studies have found that opiates, cannabis, amphetamines, hallucinogens, inhalants and benzodiazepines are often used in combination as well. The results of a long-term or longitudinal study on substance use led the researchers to observe that excessively using or relying on one drug increased the probability of excessively using or relying on another drug.